Mixed cytomegalovirus genotypes in HIV positive mothers show compartmentalization and distinct patterns of transmission to infants

  1. Juanita Pang
  2. Jennifer A Slyker
  3. Sunando Roy
  4. Josephine Bryant
  5. Claire Atkinson
  6. Juliana Cudini
  7. Carey Farquhar
  8. Paul Griffiths
  9. James Kiarie
  10. Sofia Morfopoulou
  11. Alison C Roxby
  12. Helena Tutil
  13. Rachel Williams
  14. Soren Gantt
  15. Richard A Goldstein
  16. Judith Breuer  Is a corresponding author
  1. University College London, United Kingdom
  2. University of Washington, United States
  3. University College of London, United Kingdom
  4. University of Nairobi, Kenya
  5. University of Montréal, Canada

Abstract

Cytomegalovirus (CMV) is the commonest cause of congenital infection (cCMVi) and particularly so among infants born to HIV-infected women. Studies of cCMVi pathogenesis are complicated by the presence of multiple infecting maternal CMV strains, especially in HIV-positive women, and the large, recombinant CMV genome. Using newly developed tools to reconstruct CMV haplotypes, we demonstrate anatomic CMV compartmentalization in five HIV-infected mothers and identify the possibility of congenitally transmitted genotypes in three of their infants. A single CMV strain was transmitted in each congenitally infected case, and all were closely related to those that predominate in the cognate maternal cervix. Compared to non-transmitted strains, these congenitally transmitted CMV strains showed statistically significant similarities in 19 genes associated with tissue-tropism and immunomodulation. In all infants, incident superinfections with distinct strains from breast milk were captured during follow-up. The results represent potentially important new insights into the virologic determinants of early CMV infection.

Data availability

Sequence reads have been deposited in NCBI Sequence Read Archive under BioProject ID PRJNA605798.

Article and author information

Author details

  1. Juanita Pang

    Division of Infection and Immunity, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  2. Jennifer A Slyker

    Department of Global Health, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Sunando Roy

    Division of Infection and Immunity, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Josephine Bryant

    Division of Infection and Immunity, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  5. Claire Atkinson

    Division of Infection and Immunity, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  6. Juliana Cudini

    Division of Infection and Immunity, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  7. Carey Farquhar

    Departments of Global Health, Epidemiology, Medicine (Div. Allergy and Infectious Diseases), University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Paul Griffiths

    University College of London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  9. James Kiarie

    Department of Obstetrics and Gynaecology, University of Nairobi, Nairobi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  10. Sofia Morfopoulou

    Division of Infection and Immunity, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  11. Alison C Roxby

    Department of Global Health, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Helena Tutil

    Division of Infection and Immunity, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  13. Rachel Williams

    Division of Infection and Immunity, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  14. Soren Gantt

    Infectious Diseases and Immunology, University of Montréal, Montréal, Canada
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5743-3606
  15. Richard A Goldstein

    Division of Infection and Immunity, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5148-4672
  16. Judith Breuer

    Division of Infection and Immunity, University College London, London, United Kingdom
    For correspondence
    j.breuer@ucl.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8246-0534

Funding

EUFP7 (304875)

  • Judith Breuer

UCL/UCLH NIHR Biomedical Research Centre

  • Judith Breuer

Sir Henry Wellcome Fellowship

  • Sofia Morfopoulou

Sir Henry Wellcome Fellowships

  • Josephine Bryant

Wellcome Trust (204870)

  • Paul Griffiths

NIH National Institute of Allergy and Infectious Diseases (AI087369)

  • Jennifer A Slyker

NIH National Institute of Allergy and Infectious Diseases (AI027757)

  • Jennifer A Slyker

NIH National Institute of Allergy and Infectious Diseases (AI076105)

  • Carey Farquhar

NIH National Institute of Allergy and Infectious Diseases (AI087399)

  • Carey Farquhar

National Institute of Child Health and Human Development (HD057773-01)

  • Carey Farquhar

National Institute of Child Health and Human Development (HD054314)

  • Carey Farquhar

Rosetreees Trust PhD Studentship (M876)

  • Juanita Pang

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Margaret Stanley, University of Cambridge, United Kingdom

Version history

  1. Received: September 17, 2020
  2. Accepted: December 31, 2020
  3. Accepted Manuscript published: December 31, 2020 (version 1)
  4. Version of Record published: January 13, 2021 (version 2)

Copyright

© 2020, Pang et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,039
    views
  • 151
    downloads
  • 17
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Juanita Pang
  2. Jennifer A Slyker
  3. Sunando Roy
  4. Josephine Bryant
  5. Claire Atkinson
  6. Juliana Cudini
  7. Carey Farquhar
  8. Paul Griffiths
  9. James Kiarie
  10. Sofia Morfopoulou
  11. Alison C Roxby
  12. Helena Tutil
  13. Rachel Williams
  14. Soren Gantt
  15. Richard A Goldstein
  16. Judith Breuer
(2020)
Mixed cytomegalovirus genotypes in HIV positive mothers show compartmentalization and distinct patterns of transmission to infants
eLife 9:e63199.
https://doi.org/10.7554/eLife.63199

Share this article

https://doi.org/10.7554/eLife.63199

Further reading

    1. Genetics and Genomics
    Mohammad Alfatah, Jolyn Jia Jia Lim ... Frank Eisenhaber
    Research Article

    Uncovering the regulators of cellular aging will unravel the complexity of aging biology and identify potential therapeutic interventions to delay the onset and progress of chronic, aging-related diseases. In this work, we systematically compared genesets involved in regulating the lifespan of Saccharomyces cerevisiae (a powerful model organism to study the cellular aging of humans) and those with expression changes under rapamycin treatment. Among the functionally uncharacterized genes in the overlap set, YBR238C stood out as the only one downregulated by rapamycin and with an increased chronological and replicative lifespan upon deletion. We show that YBR238C and its paralog RMD9 oppositely affect mitochondria and aging. YBR238C deletion increases the cellular lifespan by enhancing mitochondrial function. Its overexpression accelerates cellular aging via mitochondrial dysfunction. We find that the phenotypic effect of YBR238C is largely explained by HAP4- and RMD9-dependent mechanisms. Furthermore, we find that genetic- or chemical-based induction of mitochondrial dysfunction increases TORC1 (Target of Rapamycin Complex 1) activity that, subsequently, accelerates cellular aging. Notably, TORC1 inhibition by rapamycin (or deletion of YBR238C) improves the shortened lifespan under these mitochondrial dysfunction conditions in yeast and human cells. The growth of mutant cells (a proxy of TORC1 activity) with enhanced mitochondrial function is sensitive to rapamycin whereas the growth of defective mitochondrial mutants is largely resistant to rapamycin compared to wild type. Our findings demonstrate a feedback loop between TORC1 and mitochondria (the TORC1–MItochondria–TORC1 (TOMITO) signaling process) that regulates cellular aging processes. Hereby, YBR238C is an effector of TORC1 modulating mitochondrial function.

    1. Genetics and Genomics
    2. Neuroscience
    Céline Petitgas, Laurent Seugnet ... Serge Birman
    Research Article

    Adenine phosphoribosyltransferase (APRT) and hypoxanthine-guanine phosphoribosyltransferase (HGPRT) are two structurally related enzymes involved in purine recycling in humans. Inherited mutations that suppress HGPRT activity are associated with Lesch–Nyhan disease (LND), a rare X-linked metabolic and neurological disorder in children, characterized by hyperuricemia, dystonia, and compulsive self-injury. To date, no treatment is available for these neurological defects and no animal model recapitulates all symptoms of LND patients. Here, we studied LND-related mechanisms in the fruit fly. By combining enzymatic assays and phylogenetic analysis, we confirm that no HGPRT activity is expressed in Drosophila melanogaster, making the APRT homolog (Aprt) the only purine-recycling enzyme in this organism. Whereas APRT deficiency does not trigger neurological defects in humans, we observed that Drosophila Aprt mutants show both metabolic and neurobehavioral disturbances, including increased uric acid levels, locomotor impairments, sleep alterations, seizure-like behavior, reduced lifespan, and reduction of adenosine signaling and content. Locomotor defects could be rescued by Aprt re-expression in neurons and reproduced by knocking down Aprt selectively in the protocerebral anterior medial (PAM) dopaminergic neurons, the mushroom bodies, or glia subsets. Ingestion of allopurinol rescued uric acid levels in Aprt-deficient mutants but not neurological defects, as is the case in LND patients, while feeding adenosine or N6-methyladenosine (m6A) during development fully rescued the epileptic behavior. Intriguingly, pan-neuronal expression of an LND-associated mutant form of human HGPRT (I42T), but not the wild-type enzyme, resulted in early locomotor defects and seizure in flies, similar to Aprt deficiency. Overall, our results suggest that Drosophila could be used in different ways to better understand LND and seek a cure for this dramatic disease.